← Open Payments lookup

JENNIFER DISMUKES: Open Payments

NPI 1396818076 · SKILLMAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,771 in 64 payments from 10 companies in 2025. Trend: 2023 $274 · 2024 $1,044 · 2025 $12,771

Consulting: $10,015Food & beverage: $1,770Travel & lodging: $986
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.14$11,470
Otsuka America Pharmaceutical, Inc.7$385
Axsome Therapeutics, Inc.2$243
Teva Pharmaceuticals USA, Inc.17$218
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$205
Alkermes, Inc.6$114
Luye Pharma (USA) Ltd.5$72
Lundbeck LLC2$32
Takeda Pharmaceuticals U.S.A., Inc.1$18
IDORSIA PHARMACEUTICALS US INC1$14

Products named: COBENFY, REXULTI, Auvelity, CAPLYTA, UZEDY, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.

Industry payments across NJ — which companies pay providers there.